FrancophonIA/ELRC3.0 huggingface dataset:
English: Antibiotic eye drops may also be given before and after the Macugen injection, to prevent eye infection.
Slovenian: Za zaščito pred okužbo se bolniku pred injiciranjem zdravila Macugen in po njem lahko dajo antibiotične kapljice za oko.
English: How does Macugen work?
Slovenian: Kako zdravilo Macugen deluje?
English: This summary was last updated in August 2008.
Slovenian: Povzetek je bil nazadnje posodobljen 08-2008.
English: Safety of the product was satisfactorily demonstrated.
Slovenian: Varnost zdravila je bila zadovoljivo dokazana.
English: The vaccine is given by intramuscular injection.
Slovenian: Cepivo se daje z intramuskularno injekcijo.
English: The Marketing Authorisation was subsequently renewed.
Slovenian: Dovoljenje za promet z zdravilom je bilo kasneje obnovljeno.
English: Neocolipor contains inactivated strains of E. coli expressing the adhesins F4ab (K88ab), F4ac (K88ac), F4ad (|K88 ad) F5 (K99) F6 (987P) and F41.
Slovenian: Neocolipor vsebuje neaktiviran bakterijski sev E. coli, ki izraža adhezine F4ab (K88ab), F4ac (K88ac), F4ad (|K88 ad) F5 (K99) F6 (987P) in F41.
English: Vaccination may cause a slight rise in the animal's body temperature (less than 1.5°C during a maximum period of 24 hours).
Slovenian: Cepljenje lahko povzroči rahlo povišanje telesne temperature živali (manj kot 1,5 °C v obdobju do največ 24 ur).
English: The results presented showed statistical significance between vaccinates and non-vaccinates and thus demonstrated the efficacy of the vaccine.
Slovenian: Predstavljeni rezultati so pokazali statistično pomembno razliko med živalmi, ki so bile cepljene, in tistimi, ki niso bile, s tem pa so dokazali učinkovitost cepiva.
English: Gilts are animals which have produced fewer than two litters.
Slovenian: Mladice so živali, ki so imele manj kot dve legli.
English: The European Commission granted a marketing authorisation, valid throughout the European Union, for Neocolipor to Mérial on 9 August 2002.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Neocolipor, veljavno po vsej Evropski uniji, odobrila družbi Mérial dne 9. avgusta 2001.
English: If you need more information about your animal's medical condition or treatment, contact your veterinarian.
Slovenian: Če potrebujete več informacij o zdravstvenem stanju ali zdravljenju živali, se posvetujte z veterinarjem.
English: Safety data were also presented for the recommended use of the product both under laboratory conditions and in the field.
Slovenian: Predstavljeni so bili tudi podatki o varnosti za priporočeno uporabo zdravila v laboratorijskih pogojih in na terenu.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) NEOCOLIPOR EPAR summary for the public
Slovenian: EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) NEOCOLIPOR Povzetek EPAR za javnost
English: Re-vaccination was shown to be effective at the intervals recommended.
Slovenian: Dokazano je bilo, da je bila revakcinacija učinkovita v priporočenih časovnih razmikih.
English: Information on the prescription status of this product may be found on the label/outer package.
Slovenian: Informacije o predpisovanju tega izdelka so na voljo na nalepki/zunanji ovojnini.
English: A booster vaccination is given 2 weeks prior to each subsequent farrowing.
Slovenian: Obnovitveno cepljenje se izvede 2 tedna pred vsako naslednjo prasitvijo.
English: Other information about Neocolipor:
Slovenian: Druge informacije o zdravilu Neocolipor:
English: The Committee for Medicinal Products for Veterinary Use (CVMP) considered that, in accordance with European Union requirements, Neocolipor had been shown to be effective in the reduction of neonatal enterotoxicosis in piglets.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je menil, da se je zdravilo Neocolipor v skladu z zahtevami Evropske unije izkazalo kot učinkovito pri zmanjševanju poporodne enterotoksemije pri pujskih.
English: Zero days (the vaccine does not contain any ingredients that are likely to pose a risk for consumers of vaccinated animals at the recommended dose).
Slovenian: Nič dni (cepivo ne vsebuje učinkovin, ki bi lahko pomenile tveganje za ljudi, ki zaužijejo meso živali, ki so bile cepljene v priporočenem odmerku).
English: Neocolipor is an inactivated vaccine intended to be used to reduce neonatal enterotoxicosis (a bacterial infection caused by strains of E.coli) in very young piglets.
Slovenian: Zdravilo Neocolipor je neaktivirano cepivo, namenjeno zmanjševanju poporodne enterotoksemije (bakterijske okužbe, ki jo povzročajo sevi bakterije E.coli) pri zelo mladih pujskih.
English: The vaccine is intended for use 5-7 weeks before the birth of the litter (farrowing) with a second vaccination at 2 weeks prior to farrowing.
Slovenian: Cepljenje izvedemo dvakrat, in sicer prvo 5-7 tednov pred rojstvom legla (prasitvijo) ter drugo 2 tedna pred prasitvijo.
English: Vaccination of the mother animal (sows and gilts) enables the offspring to receive a passive immunity during their first days of life against neonatal enterotoxicosis caused by E. coli strains carrying the adhesins F4, F5, F6 and F41.
Slovenian: Cepljenje svinj in mladic omogoča, da njihov zarod v prvih dneh življenja razvije pasivno imunost na poporodno enterotoksemijo, katere povzročitelj so sevi bakterije E. coli, ki nosijo adhezine F4, F5, F6 in F41.
English: What benefit has Neocolipor shown during the studies?
Slovenian: Kakšne koristi je zdravilo Neocolipor izkazalo med študijami?
English: In the case of accidental self injection, seek medical advice immediately and show the package insert or label to a physician.
Slovenian: Če si zdravilo nenamerno vbrizgate, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino zdravila.
English: A number of trials were carried out in both the laboratory and in the field in order to assess the efficacy of the product.
Slovenian: Da bi se ocenila učinkovitost zdravila, so bile izvedene številne študije v laboratoriju in na terenu.
English: Why has Neocolipor been approved?
Slovenian: Zakaj je bilo zdravilo Neocolipor odobreno?
English: How has Neocolipor been studied?
Slovenian: Kako je bilo zdravilo Neocolipor raziskano?
English: What is Neocolipor used for?
Slovenian: Za kaj se zdravilo Neocolipor uporablja?
English: Neocolipor is administered to female pigs - both sows and gilts - in order to immunise their offspring against neonatal enterotoxicosis.
Slovenian: Zdravilo Neocolipor se daje svinjam in mladicam za imunizacijo zaroda pred poporodno enterotoksemijo.
English: What are the side-effects of Neocolipor?
Slovenian: Kakšni so neželeni učinki zdravila Neocolipor?
English: What is Neocolipor?
Slovenian: Kaj je zdravilo Neocolipor?
English: How does Neocolipor work?
Slovenian: Kako zdravilo Neocolipor deluje?
English: 16ml (25mg/ml) 1 vial
Slovenian: 16ml (25mg/ml) 1 viala
English: <EMA procedure number> <MA (EU) number> (Invented) name Strength Pharmaceutical form Route of administration Immediate Packaging <Content (concentration)> Pack size
Slovenian: <Številka postopka EMA> <Številka (EU) dovoljenja za promet> (Izmišljeno) ime Jakost Farmacevtska oblika Pot uporabe Stična ovojnina <Vsebina (koncentracija)> Velikost pakiranja
English: 3 - How to take Keppra
Slovenian: 3 - Kako jemati zdravilo Keppra
English: Keppra must be taken twice a day, once in the morning and once in the evening, at about the same time each day.
Slovenian: Zdravilo Keppra morate jemati dvakrat na dan, enkrat zjutraj in enkrat zvečer, vsak dan ob približno istem času.
English: Adopted at the 26-29 September 2016 PRAC
Slovenian: Sprejeto na seji odbora PRAC med 26. in 29. septembrom 2016
English: Summary of product characteristics (except for products for external use on the skin)
Slovenian: Povzetek glavnih značilnosti zdravila (razen za zdravila za zunanjo uporabo na koži)
English: Tell your doctor immediately and stop taking metronidazole if you develop:
Slovenian: Nemudoma obvestite svojega zdravnika in prenehajte jemati metronidazol, če se pojavijo:
English: Package leaflet (except for products for external use on the skin) 2 - What you need to know before you use metronidazole Warnings and precautions
Slovenian: Navodilo za uporabo (razen za zdravila za zunanjo uporabo na koži) 2 - Kaj morate vedeti, preden boste uporabili metronidazol Opozorila in previdnostni ukrepi
English: In this population, metronidazole should therefore be used after careful benefit-risk assessment and only if no alternative treatment is available.
Slovenian: Pri tej populaciji se sme zato metronidazol uporabljati šele po temeljiti oceni razmerja med tveganji in koristmi ter samo, če ni na voljo drugega zdravljenja.
English: When you will first start taking Keppra, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose.
Slovenian: Na začetku jemanja zdravila Keppra vam bo zdravnik, preden vam bo predpisal najmanjši običajni odmerek, za dva tedna predpisal manjši odmerek.
English: Levetiracetam(oral solution) - Medication errors associated with accidental overdose (EPITT no 10519)
Slovenian: Levetiracetam (peroralna suspenzija) - napake pri uporabi zdravila, povezane z nenamernim prevelikim odmerjanjem (EPITT-št. 10519)
English: After measuring the correct dose with an appropriate syringe, Keppra oral solution may be diluted in a glass of water or baby's bottle.
Slovenian: Po tem, ko ste izmerili pravilen odmerek z ustrezno brizgo, lahko peroralno raztopino zdravila Keppra razredčite v kozarcu vode ali v steklenički za hranjenje otrok.
English: If the liver function tests become markedly elevated during treatment, the drug should be discontinued.
Slovenian: Če preiskave delovanja jeter med zdravljenjem pokažejo izrazito povišane vrednosti, je treba uporabo zdravila prekiniti.
English: Metronidazole - Severe hepatic and neurologic toxicity in patients with Cockayne syndrome (EPITT no 18663)
Slovenian: Metronidazol - resna jetrna in nevrološka toksičnost pri bolnikih s Cockaynovim sindromom (EPITT-št. 18663)
English: Liver function tests must be performed just prior to the start of therapy, throughout and after end of treatment until liver function is within normal ranges, or until the baseline values are reached.
Slovenian: Neposredno pred začetkom zdravljenja, med zdravljenjem in po koncu zdravljenja je treba izvajati preiskave delovanja jeter, dokler njihovo delovanje ne doseže normalnih vrednosti ali dokler niso dosežene izhodiščne vrednosti.
English: Patients with Cockayne syndrome should be advised to immediately report any symptoms of potential liver injury to their physician and stop taking metronidazole.
Slovenian: Bolnikom s Cockaynovim sindromom je treba svetovati, naj svojega zdravnika nemudoma obvestijo o vseh simptomih morebitne poškodbe jeter in prenehajo jemati metronidazol.
English: The exact quantity of oral solution formulation should be delivered using the syringe provided in the cardboard box.
Slovenian: Natančno količino peroralne raztopine morate dati z uporabo brizge, ki se nahaja v škatli.
English: • Stomach pain, anorexia, nausea, vomiting, fever, malaise, fatigue, jaundice, dark urine, putty or mastic coloured stools or itching.
Slovenian: splošno slabo počutje, utrujenost, zlatenica, temen urin, rumenkasto-sivo ali zelenkasto blato ali srbenje.
English: Dose in children 6 months and older weighing less than 50 Kg Dose in infants (6 to 23 months), children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg:
Slovenian: Odmerjanje pri dojenčkih, starejših od 6 mesecev, lažjih od 50 kg Odmerjanje pri dojenčkih (od 6 do 23 mesecev), pri otrocih (od 2 do 11 let) in mladostnikih (od 12 do 17 let), lažjih od 50 kg
English: If you are affected by Cockayne syndrome, your doctor should also monitor your liver function frequently while you are being treated with metronidazole and afterwards.
Slovenian: Če trpite za Cockaynovim sindromom, mora vaš zdravnik med zdravljenjem z metronidazolom in po njem pogosto spremljati delovanje vaših jeter.
English: Dose in infants (1 month to less than 6 months):
Slovenian: Odmerjanje pri dojenčkih (od 1 meseca do manj kot 6 mesecev) telesna masa
English: Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more: Measure the appropriate dosage using the 10 ml syringe included in the package for patients of 4 years and above.
Slovenian: Odmerjanje pri odraslih in mladostnikih (od 12 do 17 let), težjih od 50 kg Ustrezen odmerek izmerite z uporabo 10-mililitrske brizge, vključene v pakiranje za bolnike, stare 4 leta in več.
English: Dose in children 6 months and older weighing less than 50 kg: Weight
Slovenian: Odmerjanje pri otrocih, starih 6 mesecev in več, lažjih od 50 kg telesna masa nad 50 kg
English: General dose: between 0.14 ml (14 mg) and 0.42 ml (42 mg) per kg bodyweight each day, divided in 2 intakes per day.
Slovenian: Običajni odmerek: med 0,14 ml (14 mg) in 0,42 ml (42 mg) na kg telesne mase vsak dan, razdeljen na dva enaka odmerka na dan.
English: General dose: Keppra is taken twice daily, in two equally divided doses, each individual dose being measured between 0.1 ml (10mg) and 0.3 ml (30mg), per kg bodyweight of the child. (see table below for dose examples).
Slovenian: Običajni odmerek: zdravilo Keppra se jemlje dvakrat na dan v dveh enakih odmerkih, pri čemer vsak posamezni odmerek znaša od 0,1 ml (10 mg) do 0,3 ml (30 mg) na kg telesne mase otroka (za primere odmerkov glejte spodnjo preglednico).
English: General dose: between 0.2 ml (20 mg) and 0.6 ml (60 mg) per kg bodyweight each day, divided in 2 intakes per day.
Slovenian: Običajni odmerek: med 0,2 ml (20 mg) in 0,6 ml (60 mg) na kg telesne mase vsak dan, razdeljen na dva enaka odmerka na dan.
English: General dose: Keppra is taken twice daily, in two equally divided doses, each individual dose being measured between 0.07 ml (7mg) and 0.21 ml (21mg), per kg bodyweight of the infant.
Slovenian: Običajni odmerek: zdravilo Keppra se jemlje dvakrat na dan v dveh enakih odmerkih, pri čemer vsak posamezni odmerek znaša od 0,07 ml (7 mg) do 0,21 ml (21 mg) na kg telesne mase dojenčka (za primere odmerkov glejte spodnjo preglednico).
English: Cases of severe hepatotoxicity/acute hepatic failure, including cases with a fatal outcome with very rapid onset after treatment initiation in patients with Cockayne syndrome have been reported with products containing metronidazole for systemic use.
Slovenian: Ob uporabi zdravil, ki vsebujejo metronidazol za sistemsko zdravljenje, so pri bolnikih s Cockaynovim sindromom poročali o primerih resne hepatotoksičnosti/akutne odpovedi jeter, vključno s primeri s smrtnim izidom z zelo hitrim pojavom po začetku zdravljenja.
English: Monotherapy
Slovenian: Samostojno zdravljenje
English: For infants 1 month to less than 6 months, measure the appropriate dosage using the 1 ml syringe included in the package.
Slovenian: Odmerjanje pri dojenčkih (od 1 meseca do manj kot 6 mesecev) Za dojenčke, stare od 1 meseca do manj kot 6 mesecev, ustrezen odmerek izmerite z uporabo 1-mililitrske brizge, vključene v pakiranje.
English: Cases of severe liver toxicity/acute liver failure, including cases with a fatal outcome, in patients with Cockayne syndrome have been reported with product containing metronidazole.
Slovenian: Ob uporabi zdravil, ki vsebujejo metronidazol, so pri bolnikih s Cockaynovim sindromom poročali o primerih resne jetrne toksičnosti/akutne odpovedi jeter, vključno s primeri s smrtnim izidom.
English: For children 6 months to 4 years, measure the appropriate dosage using the 3 ml syringe included in the package.
Slovenian: Za otroke, stare od 6 mesecev do manj kot 4 leta, ustrezen odmerek izmerite z uporabo 3-mililitrske brizge, vključene v pakiranje.
English: Package leaflet
Slovenian: Dopolnilno zdravljenje
English: Measure the appropriate dosage using the 10 ml syringe included in the package for patients 4 years and above.
Slovenian: Odmerjanje pri odraslih in mladostnikih (od 16. leta starosti) Ustrezen odmerek izmerite z uporabo 10-mililitrske brizge, vključene v pakiranje za bolnike, stare 4 leta in več.
English: Outcome of a referral procedure under Article 35 of Directive 2001/82/EC (EMEA/V/A/130)
Slovenian: Izid napotitvenega postopka v skladu s členom 35 Direktive 2001/82/ES (EMEA/V/A/130)
English: The European Commission issued a decision on 20 September 2019.
Slovenian: Evropska komisija je sklep izdala 20. septembra 2019.
English: Tylosin is a macrolide antibiotic used mainly to treat infections caused by bacteria known as Grampositive bacteria.
Slovenian: Tilozin je makrolidni antibiotik, ki se uporablja predvsem za zdravljenje okužb, ki jih povzročajo bakterije, imenovane grampozitivne bakterije.
English: Why were veterinary medicines containing tylosin reviewed?
Slovenian: Zakaj so bila zdravila za uporabo v veterinarski medicini, ki vsebujejo tilozin, pregledana?
English: The Committee concluded that the injection should be divided over two injection sites (maximum 2.5 ml injection volume per injection site).
Slovenian: Odbor je sklenil, da je treba injiciranje razdeliti na dve mesti injiciranja (največ 2,5 ml volumna injiciranja na mesto injiciranja).
English: In addition, cattle may also be treated by injection given slowly into a vein.
Slovenian: Poleg tega se lahko govedo zdravi tudi s počasnim injiciranjem v veno.
English: The CVMP reviewed available data on residue depletion, which indicates how long a medicine takes to fall below maximum residue limits (MRLs) in the animal's body.
Slovenian: Odbor CVMP je pregledal vse razpoložljive podatke o izločanju ostankov, ki je pokazatelj, kako dolgo traja, da zdravilo pade pod mejno vrednost ostankov (MRL) v telesu živali.
English: Veterinary medicines containing tylosin are used in adult cattle, calves, pigs, sheep and goats and are given by injection into the muscle.
Slovenian: Zdravila za uporabo v veterinarski medicini, ki vsebujejo tilozin, se uporabljajo pri odraslem govedu, teletih, prašičih, ovcah in kozah ter se dajejo z injiciranjem v mišico.
English: The full changes made to the product information are detailed in Annex III of the CVMP opinion under 'All documents'.
Slovenian: Vse spremembe v informacijah o zdravilu so opisane v Prilogi III mnenja odbora CVMP pod zavihkom
English: Based on the evaluation of the currently available data and the scientific discussion within the Committee, the CVMP concluded that, for 49 out of 50 products, those containing benzyl alcohol and propylene glycol as a non-active ingredient, the withdrawal periods for meat and offal from treated sheep should be 42 days, while the withdrawal periods for milk from treated sheep should be 108 hours.
Slovenian: Na podlagi ocene trenutno razpoložljivih podatkov in znanstvene razprave v odboru CVMP je ta zaključil, da bi morala biti pri 49 od 50 proizvodov, ki vsebujejo benzilalkohol in propilenglikol kot neaktivno sestavino, karenca za meso in drobovino zdravljenih ovac 42 dni, karenca za mleko zdravljenih ovac pa 108 ur.
English: Therefore, the CVMP concluded that the benefit-risk balance for the veterinary medicine Tilocen is not favourable for sheep and recommended a change to its marketing authorisation to remove any reference to use in sheep.
Slovenian: Zato je odbor CVMP zaključil, da razmerje med tveganji in koristmi zdravila Tilocen za uporabo v veterinarski medicini ni ugodno pri ovcah, in priporočil spremembo dovoljenja za promet s tem zdravilom, v katerem je treba odstraniti vsa sklicevanja na uporabo pri ovcah.
English: The Dutch authority considered that the withdrawal periods for sheep in the EU might not be adequate to ensure consumer safety, noting that withdrawal periods differed across the EU: from 8 to 42 days for sheep meat and offal and from 4 to 7 days for sheep milk.
Slovenian: Ta organ je namreč menil, da karence za ovce v EU naj ne bi bile ustrezne za zagotovitev varstva potrošnikov, saj so se med posameznimi državami EU razlikovale: od 8 do 42 dni za ovčje meso in organe ter od 4 do 7 dni za ovčje mleko.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that for some of these medicines, the maximum injection volume per site and the withdrawal periods for sheep meat, offal and milk should be changed.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da je treba za nekatera od teh zdravil spremeniti največjo dovoljeno količino injiciranja na posamezno mesto ter karence za ovčje meso, drobovino in mleko.
English: For one medicine, Tilocen, which contains the non-active ingredient polyethylene glycol 400, there were no data available that could be used to set adequate withdrawal periods in sheep.
Slovenian: Za zdravilo Tilocen, ki vsebuje neaktivno sestavino polietilen glikol 400, ni bilo na voljo nobenih podatkov, ki bi se lahko uporabili za določitev ustrezne karence pri ovcah.
English: However, for one medicine, Tilocen, the Committee concluded that there were insufficient data to determine the withdrawal period and that it should therefore no longer be used in sheep.
Slovenian: Pri enem zdravilu, Tilocen, pa je ugotovil, da ni dovolj podatkov za določitev karence in da se to zato ne sme več uporabljati pri ovcah.
English: On 20 June 2019, the European Medicines Agency completed a review of the withdrawal periods for injectable veterinary medicines containing tylosin when used in sheep.
Slovenian: Evropska agencija za zdravila je 20. junija 2019 končala pregled karenc pri zdravilih za uporabo v veterinarski medicini, ki vsebujejo tilozin za injiciranje, kadar se uporabljajo pri ovcah.
English: On 28 September 2018, the Dutch medicines authority requested that the CVMP review all available data and recommend withdrawal periods for milk, meat and offal from sheep treated with injectable veterinary medicines containing tylosin.
Slovenian: Nizozemski organ za zdravila je 28. septembra 2018 zahteval, da odbor CVMP pregleda vse razpoložljive podatke in priporoči karenco za mleko, meso in organe ovac, zdravljenih z zdravili za uporabo v veterinarski medicini, ki vsebujejo tilozin za injiciranje.
English: The CVMP recommended the variation of the marketing authorisations for these veterinary medicines.
Slovenian: Zato je priporočil spremembo dovoljenj za promet s temi zdravili za uporabo v veterinarski medicini.
English: This summary was last updated in 10-2014
Slovenian: Povzetek je bil nazadnje posodobljen 10-2014.
English: This medicine is the same as Stalevo, which is already authorised in the European Union (EU).
Slovenian: To zdravilo je enako zdravilu Stalevo, ki je že odobreno v Evropski uniji (EU).
English: Corbilta is used when these fluctuations cannot be treated with the standard combination alone.
Slovenian: Zdravilo Corbilta se uporablja, kadar teh fluktuacij ni mogoče zdraviti samo s standardno kombinacijo.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Corbilta on 11 November 2013.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Corbilta, veljavno po vsej Evropski uniji, izdala 11 novembra 2013.
English: What measures are being taken to ensure the safe and effective use of Corbilta?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Corbilta?
English: Patients then lose their ability to control their movements reliably.
Slovenian: Bolniki nato izgubijo sposobnost zanesljivega nadzora nad svojimi gibi.
English: Other information about Corbilta
Slovenian: Druge informacije o zdravilu Corbilta
English: This is a summary of the European public assessment report (EPAR) for Corbilta.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Corbilta.
English: The use of combinations of levodopa and carbidopa is well established, having being in use since the mid1970s.
Slovenian: Uporaba kombinacij levodope in karbidope je dobro uveljavljena, in sicer od sredine sedemdesetih let prejšnjega stoletja.
English: Levodopa / carbidopa / entacapone
Slovenian: Corbilta levodopa/karbidopa/entakapon